Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine versus continuous-infusion 5-fluorouracil with preoperative radiotherapy in rectal cancer
2009-017840-15Phase 3Completed
- Sponsor
- DSC Services
- Start
- Feb 2010
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in rectal cancer comparing Capecitabine + radiotherapy with Continuous 5-fluorouracil + radiotherapy (2 arms). Primary endpoint: Complete histopathological remission rate. Started Feb 2010; status: completed.
02
Drugs
capecitabinefluorouracil
03
Conditions
rectal cancer
Beyond the preview
Go deeper on 2009-017840-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017840-15.